Skip to content

Advertisement

The official journal of Orphanet, the portal for rare diseases and orphan drugs.

New Content Item

Our new Editor-in-Chief

BMC is proud to present the new Editor-in-Chief for Orphanet Journal of Rare DIseases, Professor Francesc Palau! Please click here to learn more about Professor Palau, and his career in the world of rare diseases.

New Content Item

Call for papers: Rare Disease in the U.S.

Orphanet Journal of Rare Diseases is happy to open up a call for papers, for a new thematic series: Rare Disease in the United States. Please click here to see how you can contribute to this look at rare disease work in one of the field's biggest areas!

Rare Disease Day: 2018's Findacure winner

We are proud to publish the 2018 winner of Findacure’s “Student Voice” essay contest! A medical student takes the reader through a journey of how her eyes were opened to the importance of rare disease.

Editor-in-Chief

Francesc Palau, Sant Joan de Déu Children's Hospital and CIBERER, Spain 

OJRD reviews

Over the last decade-plus, Orphanet Journal of Rare Diseases has served as a leading home for the latest reviews on rare diseases and orphan drugs. This is very important work as often, reviews will be some of the best sources of information about rare diseases and their evolution. Please take a look at some of our most recent work in this essential vein.

Read here

Articles

  1. Content type: Review

      |  

    Authors: María Torres-Durán, José Luis Lopez-Campos, Miriam Barrecheguren, Marc Miravitlles, Beatriz Martinez-Delgado, Silvia Castillo, Amparo Escribano, Adolfo Baloira, María Mercedes Navarro-Garcia, Daniel Pellicer, Lucía Bañuls, María Magallón, Francisco Casas and Francisco Dasí

  1. Content type: Review

      |  

    Authors: Renzo Galanello and Raffaella Origa

  2. Content type: Review

      |  

    Authors: Nicole R Tartaglia, Susan Howell, Ashley Sutherland, Rebecca Wilson and Lennie Wilson

Most accessed articles RSS

View all articles

Featured series: Spinraza

One of the journals in our extended family, Gene Therapy, is featuring a special issue this month, entitled "Spinraza and advanced therapies: a stakeholder special". This issue is a vital resource for all stakeholders in the development of advanced therapies such as Spinraza, which is used to treat spinal muscular atrophy.

ADA-SCID

New Horizons in the Management of ADA-SCID, Springer Healthcare IME’s independent educational resource, is pleased to share its most recent updates: interviews at ESID, summaries of the latest research, free access to full-text articles, and full editorials. Coming soon: interactive patient cases, an on-demand webinar, and more expert interviews. The portal is for Paediatric/Adult Immunologists, Gene and Cell Therapy Clinicians, Transplant Specialists, Paediatricians and Haematologists designed to educate healthcare professionals who are presented with ADA-SCID patients. This educational activity is supported by an educational grant from GlaxoSmithKline.

Read here

New Content Item

Call for papers: Rare Disease in Spain

Orphanet Journal of Rare Diseases is excited to open up a call for papers, for a new thematic series: Rare Disease in Spain. Please click here to see how you can contribute a submission to this look at rare disease work in one of the field's biggest areas!

Rare Disease Day quiz

Our annual Rare Disease Day Quiz has returned to the BMC "On Medicine" blog! Test your knowledge of rare diseases and most importantly, learn more about them. Feel free to share your score with us at @ojrarediseases and try last year's edition

Aims and scope

Orphanet Journal of Rare Diseases is an open access, peer-reviewed journal that encompasses all aspects of rare diseases and orphan drugs. The journal publishes high-quality reviews on specific rare diseases. In addition, the journal may consider articles on clinical trial outcome reports, either positive or negative, and articles on public health issues in the field of rare diseases and orphan drugs. The journal does not accept case reports.

About Orphanet

Orphanet is the reference portal for information on rare diseases and orphan drugs. It offers a range of freely accessible services:

Latest Tweets

Advertisement

Affiliated with

  • New Content Item
  • Orphanet Journal of Rare Diseases is the official journal of Orphanet, the portal for rare diseases and orphan drugs.

2017 Journal Metrics

Advertisement